DOI : 10.1055/s-00035024

Thrombosis and Haemostasis

Issue 05 · Volume 46 · 1981 DOI: 10.1055/s-008-40641


VIIIth International Congress on Thrombosis and Haemostasis
Toronto, 13.07 – 17.07.1981

Abstracts (HTML) List of Authors
1015
van Mourik, J A; Over, J; Hellings, J A: The Effect Of Purification On The Quarternary Structure Of Factor VIII-VWF
1016
Seghatchian, M J; Mackie, I I: The Effect Of Thrombin On The Electrophoretic Mobility And Functional Activity Of Various Factor VIII Molecular Forms
1017
Barlow, Grant H; Martin, Eric S; Marder, Victor J: Hydrodynamic Studies Of Von Willebrand Protein And Factor VIIIc Using The Partition Cells In The Analytical Ultracentrifuge
1018
Cruickshank, W H; Tackaberry, E S; Palmer, D S; Rock, G A: Factor VIII Is A Calcium-Binding Protein
1019
Cruickshank, W H; Tackaberry, E S; Palmer, D S; Rock, G A: Stabilization Of FVIII: C By Calcium
1020
Lamb, M A; Reisner, H M; Cooper, H A; Wagner, R H: An Apparent Effect Of Size Distribution Of FVIIIR: Ag Multimers On Immunoradiometric Assays
1021
Over, J; van Mourik, J A; van den Brink-Zantingh, P; Smit-Jansen, R: A Methodological Investigation On The One-Stage Factor VIII Assay
1022
Conlon, C; Weinger, R; Moake, J; Rudy, C: Qualitative Defect In The Factor VIII/Von Willebrand Factor Protein (FVIII/VWF) In A Family With Hereditary Hemorrhagic Telangiectasia (HHT)
1023
Sonis, A; Andes, W A; Smith, B: Oral Bleeding In Hemophilia; A 21 Year Composite
1024
Andes, W A; Smith, W B; Wulff, K; Ohene-Frempong, K; Sonis, A; Edmunds, O: A Multidisciplinary Approach To Hemophilia At A New Regional Center; How Effective Is It?
1025
Wensley, R T; Stevens, R F; Burn, A M: Combined Factor VIII And Plasma Exchange Therapy In The Management Of Patients With Factor VIII Inhibitors
1026
White, K S; Dombrose, F A; Blatt, P M: A Rapid Screening Method To Increase Efficiency In Assaying Plasma Levels Of Factor VIII Inhibitors
1027
McClellan, S L; Hussey, C V; Fobian, J E; Pisciotta, A V: Kinetics Of Factor Viii Inhibitors In Three Non-Hemophiliac Patients
1028
ten Cate, J W; Sturk, A; Breederveld, C: Acquired F VIII Inhibitor In An Identical Subhemophilic Twin
1029
Klein, M E; Akman, S A; Wiernik, P H: Deleterious Effect Of Aspirin In The Asymptomatic Patient With Spontaneous Factor VIII Inhibitor
1030
Miller, C H; Hilgartner, M W; Lopez, D R: An Enzyme-Linked Immunosorbent Assay (ELISA) For Factor VIII Inhibitors
1031
Torres, V; Fuster, V; Moore, B; Donadio, J; Kazmier, F; Bowie, E: Blood Group (BG) Prevalence In End-Stage (ES) Renal Disease (RD): Relationship To Ristocetin Willebrand Factor (VIII: RWF) And Platelet Survival (PS)
1032
Muszbek, L; Losonczy, H; Hársfalvi, B; Nagy, I: Ristocetin Induced Platelet Factor 3 Availability, A Possible New Tool In The Diagnosis Of Von Willebrand’S Disease
1033
Silber, P; Finlay, T H: The Binding Of 125I-Von Willebrand Factor To Human Platelets In The Presence Of Ristocetin
1034
Zuhlke, J A; Mattson, J C; Bell, T G: Inhibitory Effects Of Albumin On Ristocetin-Induced Fibrinogen Precipitation
1035
Kimura, A; Aihara, M; Tanabe, K; Momma, T; Chiba, Y; Yoshida, Y: An Acquired Von Willebrand’s Disease With IgG Monoclonal Gammopathy, Normal Bleeding Time And Positive VIIIR:AG In The Vascular Endothelium
1036
Horellou, M H; Baumelow, E; Sitbon, N; Conard, J; Marie, J P; Fine, J M; Gorin, N C; Zittoun, R; Samama, M: Four Cases Of Acquired Von Willebrand's Syndrome Associated With Monoclonal Gammapathy
1037
Warrier, A I; Hillman, C; Lusher, J M: Effect Of DDAVP In Patients With Von Willebrand’s Disease And Hemophilia A
1038
Ciavarella, N; Solinas, S; Pilolli, D; Ranieri, P; Corrao, D; Antoncecchi, S; Mariani, G: Study On The Effect Of Ddavp On Factor VIII- Related Properties In Hemophilia And VWD
1039
Stephan, W; Prince, A M; Kotitschke, R: Study On Long Term Tolerance And Recovery Of Cold Sterilized Ppsb In Chimpanzees
1040
Kotitschke, R; Stephan, W; Prince, A M; Brotman, B: Thrombogenicity Results Of Cold Sterilized (ß-Propiolactone/Ultraviolet Irradiation) PPSB In Chimpanzees
1041
Melewski, D J; Ambrus, J L; Ambrus, C M; Tourbaf, K: Thrombogenicity Of Antihemophiliac Preparations With Factor VIII Inhibitor Bypassing Activity
1042
Preston, F E; Malia, R G: The Factor VIII Response To High Purity Porcine Factor VIII Concentrate In Acquired Von Willebrand’s Disease
1043
Bertaglia, E; Vertolli, U; Pengo, V; Baggio, B; Tessarin, C; Belmonte, P; Zanella, R: A Possible Role Of Factor VIII Coagulation And Cyclic Nucleotides In Promoting Endothelial Renal Injury
1044
Giustolisi, R; Musso, R; Lombardo, T; Russo, M; Cacciola, E: Factor VIII Antigen And Venostasis Test In Diabetes Mellitus. A Possible Useful Tool To Detect A Latent Endothelial Suffering
1045
Tantalo, V; Rossi, E; Cossu, M M; Migliavacca, P; Saibene, V: Relationship Between Factor VIIIR:Ag, Factor VIII C And Glycoemic Control And Vascular Complications In Insulin-Dependent Diabetics
1046
Seghatchian, M J: Assessment Of FVIII Functional Activities With Quantitative Electrophoresis
1047
Kang, E P; DeSouza, D I; Fitzpatrick, M J; O’Neill, S P: Hemagglutination Assay For Determination Of Human Factor VIII:C
1048
Pancham, N; Bogdanoff, D; Mintz, C; Wada, S; Coan, M: The Use Of Factor VIII:C Depleted Normal Plasiia In The Factor VIII:C Assay
1049
Seghatchian, M J; Mackie, I J: Characterisation Of Active Components Of Fix Concentrates Used In FVIII Inhibitor Patients
1050
Mackie, I J; Seghatchian, M J: The Functional Heterogeneity Of Clinical FVIII Concentrates
1051
Rubinstein, A: Heated Lyophilized Factor VIII Concentrate - Additional Preliminary In Vitro Studies
1052
Gaffney, P J; Mahmoud, M; Barrowcliffe, T W; Kemball-Cook, C: Development Of A Rapid Immunometric Assay For The Factor VIII Antigens In Plasma
1053
Krauss, J S; Sheard, M: Crossed Concanavalin A Affinoimmunoelectrophoresis Of Factor VIII - Related Antigen In Whole Plasma